Boundless Bio

Fierce Biotech's Quarterly IPO and M&A Roundup: Q1'24
Fierce Biotech
Wed, 04/3/24 - 11:36 am
biotech
M&A
IPOs
CG Oncology
Kyverna Therapeutics
Contineum Therapeutics
Boundless Bio
CymaBay Therapeutics
Gilead Sciences
MorphoSys
Novartis
Fusion Pharmaceuticals
AstraZeneca
Ambryx
JNJ
Inhibrix
Aventis
Boundless Bio breaks IPO lull with $100M fundraise
BioPharma Dive
Wed, 03/27/24 - 10:37 pm
Boundless Bio
IPOs
Bayer
Arch Venture Partners
cancer
Boundless Bio eyes $88M offering as spring biotech IPO market blooms
Fierce Biotech
Thu, 03/21/24 - 11:32 am
Boundless Bio
IPOs
Boundless Bio, a Bayer-backed cancer biotech, seeks an IPO
BioPharma Dive
Thu, 03/7/24 - 11:13 am
Boundless Bio
IPOs
Bayer
Arch Venture Partners
Startup Boundless Bio brings in $105M to break the circle behind cancer growth
MedCity News
Wed, 04/28/21 - 09:56 pm
Boundless Bio
funding
'A fourth revolution in cancer therapies': ARCH-backed Boundless Bio flashes big check, makes bigger promises in debut
Endpoints
Thu, 09/19/19 - 10:04 am
Boundless Bio
cancer
DNA